Swiss Drama Novartis will invest $ 23 billion in USA production and R & D

Unlock the editor’s digestion free

FT editor Roula Khalaf, chooses his favorite stories in this weekly newsletter.

Swiss Pharma Group Novartis, this said that the US tariffs will expand the production and development and development of the United States as the potential potential of potential potential potential.

Novartis, who made extensive drugs from cancer to cardiovascular drugs, said investments will allow them to produce all the main drugs in the United States. These will build seven new objects and expand others.

Vas Narasimhan, President NovartisThe investments, “Supporting our ability to make further medical advances for patients,” he said, “he said, reflecting innovationist and regulatory environment in the United States.

According to the announcement, Donald Trump won the presidential election, the latest US latest investment in the United States. Indianapolis Based Eli announced Lilly Plans to invest $ 27 billion In February, Johnson & Johnson, who owned the new form, said that last month will invest more than $ 55 billion in four factories. Astrazeneca said he would invest $ 3.5 billion in the United States in November.

This Pharmaceutical industry Last week, the global tariffs were released by Trump. However, the management said they would be applied soon.

Novartis estimates that investments will open about 4,000 jobs in about 1,000 jobs and communities and communities of the company. In the United States, the production of active drugs will be invested in the production of an area that is very confident in the industry in industry and India.

The company, Institute of research and development in San Diego, in the second US after the existing device in the Boston region. This will open an innovative cancer therapy, an innovative cancer treatment, which is a more radiotherapy version in Florida and Texas, and now treated in Indiana, New Jersey and California.

Narasimhan said the company is “completely confident” and at least 40 percent of “full confidence in the leadership of” and at least 40 percent for the year, “full confident.”